title: Expression of mammalian GPCRs in C. elegans generates novel behavioural responses to human ligands.
abstract: BACKGROUND
  G-protein-coupled receptors (GPCRs) play a crucial role in many biological processes and represent a major class of drug targets. However, purification of GPCRs for biochemical study is difficult and current methods of studying receptor-ligand interactions involve in vitro systems. Caenorhabditis elegans is a soil-dwelling, bacteria-feeding nematode that uses GPCRs expressed in chemosensory neurons to detect bacteria and environmental compounds, making this an ideal system for studying in vivo GPCR-ligand interactions. We sought to test this by functionally expressing two medically important mammalian GPCRs, somatostatin receptor 2 (Sstr2) and chemokine receptor 5 (CCR5) in the gustatory neurons of C. elegans.
  
  
  RESULTS
  Expression of Sstr2 and CCR5 in gustatory neurons allow C. elegans to specifically detect and respond to somatostatin and MIP-1alpha respectively in a robust avoidance assay. We demonstrate that mammalian heterologous GPCRs can signal via different endogenous Galpha subunits in C. elegans, depending on which cells it is expressed in. Furthermore, pre-exposure of GPCR transgenic animals to its ligand leads to receptor desensitisation and behavioural adaptation to subsequent ligand exposure, providing further evidence of integration of the mammalian GPCRs into the C. elegans sensory signalling machinery. In structure-function studies using a panel of somatostatin-14 analogues, we identified key residues involved in the interaction of somatostatin-14 with Sstr2.
  
  
  CONCLUSIONS
  Our results illustrate a remarkable evolutionary plasticity in interactions between mammalian GPCRs and C. elegans signalling machinery, spanning 800 million years of evolution. This in vivo system, which imparts novel avoidance behaviour on C. elegans, thus provides a simple means of studying and screening interaction of GPCRs with extracellular agonists, antagonists and intracellular binding partners.
authors.affiliation: Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. mst@sanger.ac.uk
authors.forename: Michelle S
authors.initials: MS
authors.lastname: Teng
authors.forename: Martijn P J
authors.initials: MP
authors.lastname: Dekkers
authors.forename: Bee Ling
authors.initials: BL
authors.lastname: Ng
authors.forename: Suzanne
authors.initials: S
authors.lastname: Rademakers
authors.forename: Gert
authors.initials: G
authors.lastname: Jansen
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Fraser
authors.forename: John
authors.initials: J
authors.lastname: McCafferty
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D001522:Behavior, Animal; D017173:Caenorhabditis elegans; D019143:Evolution, Molecular; D005786:Gene Expression Regulation; D006801:Humans; D008024:Ligands; D009474:Neurons / Q000378:metabolism*; D019713:Receptors, CCR5 / Q000235:genetics; D043562:Receptors, G-Protein-Coupled / Q000096:biosynthesis* / Q000235:genetics*; D017481:Receptors, Somatostatin / Q000235:genetics; D015398:Signal Transduction; D013004:Somatostatin / Q000378:metabolism
chemical_list: D008024:Ligands; D019713:Receptors, CCR5; D043562:Receptors, G-Protein-Coupled; D017481:Receptors, Somatostatin; D013004:Somatostatin; C093733:somatostatin receptor 2